Burd A, Levine RL, Shoben A, et al. Initial Report of the Beat AML Umbrella study for previously untreated AML: evidence of feasibility and early success in molecularly driven phase 1 and 2 studies. ASH Annual Meeting and Exposition 2018, abstract 559.
CANDOR-update: aanhoudend PFS-voordeel carfilzomib, dexamethason en daratumumab bij RRMM
feb 2022 | MM